Knowledge and opinions regarding BRCA1 and BRCA2 genetic testing among primary care physicians

Prevalence of BRCA1 and BRCA2 pathogenic variants in a large, unselected breast cancer cohort

(2018) Jingmei Li et al.   INTERNATIONAL JOURNAL OF CANCER

Underdiagnosis of Hereditary Breast Cancer: Are Genetic Testing Guidelines a Tool or an Obstacle?

(2018) Peter D. Beitsch et al.   JOURNAL OF CLINICAL ONCOLOGY

Mutation Detection in Patients With Advanced Cancer by Universal Sequencing of Cancer-Related Genes in Tumor and Normal DNA vs Guideline-Based Germline Testing

(2017) Diana Mandelker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

(2017) Karoline B. Kuchenbaecker et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Gaps in Incorporating Germline Genetic Testing Into Treatment Decision-Making for Early-Stage Breast Cancer

(2017) Allison W. Kurian et al.   JOURNAL OF CLINICAL ONCOLOGY

Effectiveness of Prophylactic Surgeries in BRCA1 or BRCA2 Mutation Carriers: A Meta-analysis and Systematic Review

(2016) X. Li et al.   CLINICAL CANCER RESEARCH

Current perspectives on recommendations for BRCA genetic testing in ovarian cancer patients

(2016) Ignace Vergote et al.   EUROPEAN JOURNAL OF CANCER

Primary care providers’ cancer genetic testing-related knowledge, attitudes, and communication behaviors: A systematic review and research agenda

(2016) Jada G. Hamilton et al.   JOURNAL OF GENERAL INTERNAL MEDICINE

Non-genetic health professionals’ attitude towards, knowledge of and skills in discussing and ordering genetic testing for hereditary cancer

(2015) Kirsten F. L. Douma et al.   Familial Cancer

Population-Wide Screening for Germline BRCA1 and BRCA2 Mutations: Too Much of a Good Thing?

(2015) Matthew B. Yurgelun et al.   JOURNAL OF CLINICAL ONCOLOGY

Hereditary Ovarian Cancer: Not OnlyBRCA1 and 2 Genes

(2015) Angela Toss et al.   Biomed Research International

Can Breast Surgeons Provide Breast Cancer Genetic Testing? An American Society of Breast Surgeons Survey

(2014) Peter D. Beitsch et al.   ANNALS OF SURGICAL ONCOLOGY

Is it time for BRCA1/2 mutation screening in the general adult population?: impact of population characteristics

(2014) Glenn E. Palomaki   GENETICS IN MEDICINE

Primary-care providers’ perceived barriers to integration of genetics services: a systematic review of the literature

(2014) Natalie A. Mikat-Stevens et al.   GENETICS IN MEDICINE

Population-Based Screening forBRCA1andBRCA2

(2014) Mary-Claire King et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Physician Risk Assessment Knowledge Regarding BRCA Genetics Testing

(2014) Jason Cohn et al.   JOURNAL OF CANCER EDUCATION

Impact of Oophorectomy on Cancer Incidence and Mortality in Women With a BRCA1 or BRCA2 Mutation

(2014) Amy P.M. Finch et al.   JOURNAL OF CLINICAL ONCOLOGY

Population Testing for Cancer Predisposing BRCA1/BRCA2 Mutations in the Ashkenazi-Jewish Community: A Randomized Controlled Trial

(2014) Ranjit Manchanda et al.   JNCI-Journal of the National Cancer Institute

Cost-effectiveness of Population Screening for BRCA Mutations in Ashkenazi Jewish Women Compared With Family History–Based Testing

(2014) Ranjit Manchanda et al.   JNCI-Journal of the National Cancer Institute

Precision Medicine Meets Public Health: Population Screening for BRCA1 and BRCA2

(2014) E. Levy-Lahad et al.   JNCI-Journal of the National Cancer Institute

Population-based screening for breast and ovarian cancer risk due toBRCA1andBRCA2

(2014) Efrat Gabai-Kapara et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Variants of uncertain significance in BRCA: a harbinger of ethical and policy issues to come?

(2014) Jae Yeon Cheon et al.   Genome Medicine

Risk Assessment, Genetic Counseling, and Genetic Testing for BRCA-Related Cancer in Women: U.S. Preventive Services Task Force Recommendation Statement

(2013) Virginia A. Moyer   ANNALS OF INTERNAL MEDICINE

Attitudes and knowledge of medical practitioners to hereditary cancer clinics and cancer genetic testing

(2013) Ian Teng et al.   Familial Cancer

A Statewide Survey of Practitioners to Assess Knowledge and Clinical Practices Regarding Hereditary Breast and Ovarian Cancer

(2013) Tuya Pal et al.   Genetic Testing and Molecular Biomarkers

Hereditary Breast and Ovarian Cancer and Other Hereditary Syndromes: Using Technology to Identify Carriers

(2012) Brian Drohan et al.   ANNALS OF SURGICAL ONCOLOGY

Significant differences among physician specialties in management recommendations of BRCA1 mutation carriers

(2011) S. U. Dhar et al.   BREAST CANCER RESEARCH AND TREATMENT

Genetic susceptibility to breast cancer

(2010) Nasim Mavaddat et al.   Molecular Oncology

Meta-analysis of Risk Reduction Estimates Associated With Risk-Reducing Salpingo-oophorectomy in BRCA1 or BRCA2 Mutation Carriers

(2009) T. R. Rebbeck et al.   JNCI-Journal of the National Cancer Institute